Month: February 2026

Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout

Initial 13-site deployment with UK subsidiary of global construction firm employing 35,600 employees across 50+ countries, validates commercial scalability and...

MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market

Ongoing Phase 3 full approval clinical trial of ateganosine holds high probability of technical success for interim and full analysis...

ENvue Medical Strengthens Patent Portfolio with New USPTO Notice of Allowance for Feeding Tube Combining Electromagnetic Navigation with Direct Visualization Through an Integrated Internal Camera

Technology supports the evolution of enteral access from blind procedures to real-time visualized placementTYLER, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE)...

Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement

Greater than 25% absolute reduction in thrombotic events with CAD-1005 versus placebo on a background of standard anticoagulant therapy, despite...

Alkeus Pharmaceuticals Announces Presentation of Investigational Oral Gildeuretinol Data During the 49th Annual Meeting of the Macula Society Being Held February 25-28

CAMBRIDGE, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of...

Functional Brands Inc. (MEHA), Launches www.Tru2u.health, a Digital Health Platform Delivering Peptides, GLP-1 Based Care with Board-Certified Telehealth Support and Clean Supplements

First Wave of Influencers with Combined Reach of Over 23 Million to Drive National AwarenessLake Oswego, Oregon--(Newsfile Corp. - February...

error: Content is protected !!